SCHEMBL5517866

SCHEMBL5517866

O=C1C=CC(=O)N1CCc1c[nH]c2ccc(O)cc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.70
HTR2C P28335 6/20 0.60
HTR1A P08908 4/20 0.58
HTR2A P28223 4/20 0.58
HTR7 P34969 4/20 0.58
CYP2D6 P10635 3/20 0.58
HTR2B P41595 3/20 0.58
HTR1D P28221 3/20 0.58
TSHR P16473 3/20 0.58
CYP3A4 P08684 3/20 0.58
CYP2C9 P11712 2/20 0.58
CYP1A2 P05177 2/20 0.58
HTR3E A5X5Y0 1/20 0.58
HTR3B O95264 1/20 0.58
DRD1 P21728 1/20 0.58
HTR1B P28222 1/20 0.58
HTR1E P28566 1/20 0.58
HTR1F P30939 1/20 0.58
DRD3 P35462 1/20 0.58
RECQL P46063 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11283499 0.85 GAA (0.69) GAAHTR2CHTR1AHTR2AHTR7
SCHEMBL5528244 0.84 TRPV1 (0.64) CYP2D6CYP3A4CYP1A2NPSR1MAPT
SCHEMBL17525726 0.83 GAA (0.66) GAAHTR2CHTR1AHTR2AHTR7
SCHEMBL2531516 0.83 GAA (1.00) GAAHTR2CHTR1AHTR2AHTR7
SCHEMBL5520092 0.82 TRPV1 (0.67) CYP2D6CYP3A4CYP1A2NPSR1MAPT
SCHEMBL10256766 0.80 HTR2A (0.64) HTR2CHTR1AHTR2AHTR7CYP2D6
SCHEMBL7002494 0.77 HTR2C (0.77) GAAHTR2CHTR1AHTR2AHTR7
SCHEMBL26508359 0.76 HTR7 (0.71) GAAHTR2CHTR1AHTR2AHTR7
SCHEMBL27095364 0.76 HTR7 (0.71) HTR2CHTR1AHTR2AHTR7CYP2D6
SCHEMBL233744 0.76 HTR2C (1.00) GAAHTR2CHTR1AHTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027310-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2007-02-01 US claimed
US-7153977-B2 Ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2006-12-26 US claimed
US-20040132981-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2004-07-08 US claimed
EP-1289561-A2 LIGAND CONJUGATES AND METHODS FOR PREPARING SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2003-03-12 EP claimed
US-20010051348-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2001-12-13 US claimed
WO-2001054731-A2 LIGAND CONJUGATES AND METHODS FOR PREPARING SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2001-08-02 WO claimed
US-20070027310-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2007-02-01 US disclosed
US-20070027310-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2007-02-01 US disclosed
US-20070027310-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2007-02-01 US disclosed
US-7153977-B2 Ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2006-12-26 US disclosed
US-20040132981-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2004-07-08 US disclosed
EP-1289561-A2 LIGAND CONJUGATES AND METHODS FOR PREPARING SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2003-03-12 EP disclosed
US-20010051348-A1 Novel ligands and methods for preparing same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2001-12-13 US disclosed
WO-2001054731-A2 LIGAND CONJUGATES AND METHODS FOR PREPARING SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051348-A1 Novel ligands and methods for preparing same ADGRF1, ADGRE5, TACR2 GAA 1918/4885HTR2C 1349/4885HTR1A 956/4885
US-20070027310-A1 Novel ligands and methods for preparing same ADGRF1, ADGRE5, TACR2 GAA 1918/4885HTR2C 1349/4885HTR1A 956/4885
US-20040132981-A1 Novel ligands and methods for preparing same ADGRF1, ADGRE5, TACR2 GAA 1918/4885HTR2C 1349/4885HTR1A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.